NDTV Profit’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer NDTV Profit’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
Dolat Capital Report
We have increased our Ebitda estimates by 7%/ 6% for FY25/FY26 to factor in the incremental revenue from this contract and upgrade to ‘Accumulate’ with revised target price of Rs 680 (25 times FY26 earnings per share), earlier Rs 620, on rising visibility.
However, no upward revision in management’s Ebitda guidance for FY25 (Rs 14.5-16 billion) despite back to back contract announcements (earlier nine year Rs 30 billion contract for agrochemical intermediate and now four year Rs 60 billion contract) indicates this profitability was already embedded in its previous guidance, now concretized.
We expect Ebitda/profit after tax compound annual growth rate of 20%/ 22% over FY23-26E, on ramp-up of recently commissioned plants and contribution from upcoming expansions.
However, persisting demand weakness in key end use segments like agro and slower than expected ramp-up in capacities meant for long term projects (older ones) continue to be the lingering concerns. Increasing revenue concentration is a key risk.
Click on the attachment to read the full report:
Also Read: ICICI Prudential Life Q3 Results Review - VNB Margin Hit Due To Adverse Product Mix: Motilal Oswal
DISCLAIMER
This report is authored by an external party. NDTV Profit does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of NDTV Profit.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.